Interesting facts
Interesting Facts about 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide
This intriguing compound, often referred to as a piperidine derivative, belongs to a class of chemicals that have gained attention in medicinal chemistry due to their multifaceted properties. Here’s a closer look at what makes this compound noteworthy:
- Medical Relevance: Compounds similar to this one have been investigated for their potential as therapeutic agents. Their structural components can play crucial roles in the efficacy of pharmacological action.
- Chirality: The presence of the piperidine ring introduces stereochemical complexities that can affect receptor interactions, making it a valuable subject for stereochemistry studies.
- Mechanism of Action: Many compounds in this class are designed to target specific neurotransmitter systems, impacting mood, pain perception, and cognitive functions, which is critical in drug development.
- Structure-Activity Relationship (SAR): The varied substitutions on the piperidine and phenyl groups make it a great candidate for SAR studies, enabling chemists to discern how different functional groups influence biological activity.
- Synthetic Routes: The synthesis of this compound may involve multi-step reactions, showcasing the intricate tools and techniques chemists apply in organic synthesis, including the use of protecting groups and selective functionalization.
As a student or scientist, understanding compounds such as this not only broadens the knowledge of organic chemistry but also enhances the ability to design and optimize new drugs that could significantly improve patient care. In the words of a renowned chemist, “The most beautiful thing we can experience is the mysterious.” This perfectly encapsulates the allure of exploring complex molecules and their potential applications in science and medicine.
Synonyms
loperamide
53179-11-6
Loperamida
Ioperamide
Loperamidum
Loperamidum [INN-Latin]
Loperamida [INN-Spanish]
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
UNII-6X9OC3H4II
EINECS 258-416-5
6X9OC3H4II
Loperamide (INN)
BRN 1558273
CHEBI:6532
DTXSID6045165
4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide
CHEMBL841
4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide
DTXCID4025165
HSDB 8344
EC 258-416-5
5-21-02-00379 (Beilstein Handbook Reference)
Fortasec
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-
NCGC00015608-04
Loperacap
LOPERAMIDE [INN]
Apo-Loperamide
Nu-Loperamide
Rho-Loperamide
Loperamidum (INN-Latin)
Kaopectate II
PMS-Loperamide
Loperamida (INN-Spanish)
Loperamide [INN:BAN]
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-diphenyl-
2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Imodium A-D Caplets
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-diphenyl-1-piperidinebutyramide
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide
CAS-53179-11-6
NSC696356
Immodium
Loperamid
LoperamideHCl
Loperamidum (Latin)
Spectrum_000374
Tocris-0840
LOPERAMIDE [MI]
LOPERAMIDE [JAN]
Prestwick0_000144
Prestwick1_000144
Prestwick2_000144
Prestwick3_000144
Spectrum2_001738
Spectrum3_001015
Spectrum4_001143
Spectrum5_001374
Lopac-L-4762
LOPERAMIDE [VANDF]
LOPERAMIDE [WHO-DD]
CBiol_001796
Lopac0_000708
Oprea1_109220
SCHEMBL28530
BSPBio_000248
BSPBio_001381
BSPBio_002769
KBioGR_000101
KBioGR_001685
KBioSS_000101
KBioSS_000854
cid_71420
DivK1c_000215
SPBio_001816
SPBio_002187
BPBio1_000274
GTPL7215
KBio1_000215
KBio2_000101
KBio2_000854
KBio2_002669
KBio2_003422
KBio2_005237
KBio2_005990
KBio3_000201
KBio3_000202
KBio3_001989
NINDS_000215
Bio1_000082
Bio1_000571
Bio1_001060
Bio2_000101
Bio2_000581
HMS1791F03
HMS1989F03
HMS2089C13
Tox21_110180
BDBM50017698
STK042086
AKOS000573892
Tox21_110180_1
CCG-204793
DB00836
SDCCGSBI-0050686.P004
4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide
IDI1_000215
IDI1_033851
NCGC00015608-01
NCGC00015608-02
NCGC00015608-03
NCGC00015608-05
NCGC00015608-06
NCGC00015608-07
NCGC00015608-08
NCGC00015608-09
NCGC00015608-11
NCGC00015608-15
NCGC00015608-24
NCGC00016828-01
NCGC00024818-01
NCGC00024818-02
NCGC00024818-03
NCGC00024818-04
NCGC00024818-05
DA-75076
SBI-0050686.P003
CAS-34552-83-5
AB00053697
NS00002516
C07080
D08144
EN300-708764
AB00053697-12
AB00053697-13
AB00053697_14
AB00053697_15
A829430
L000709
Q423751
BRD-K61250553-001-02-9
BRD-K61250553-003-05-8
BRD-K61250553-003-16-5
BRD-K61250553-003-29-8
BRD-K61250553-003-30-6
BRD-K61250553-003-32-2
LOPERAMIDE OXIDE MONOHYDRATE IMPURITY A [EP IMPURITY]
4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butyramide
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide #
258-416-5
4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butyramide(loperamide)
Solubility of 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide
The solubility of 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide (C29H33ClN2O2) can exhibit a complex profile influenced by its chemical structure. Understanding the solubility characteristics of this compound is crucial for various applications. Here are some key points regarding its solubility:
In summary, the solubility of C29H33ClN2O2 is likely limited in aqueous environments but could display better solubility in organic solvents. As with many chemical compounds, precise solubility can be determined through experimental methods under controlled conditions.